WINDTREE THERAPEUTICS INC /DE/ Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31)
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) of 0.00% for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-31.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsExpectedVolatilityRate · last filed 2017-03-31
- WINDTREE THERAPEUTICS INC /DE/ fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2013-03-31 was 101.00%.
- WINDTREE THERAPEUTICS INC /DE/ fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2016 was 0.00%, a 100.00% decline from fiscal 2015.
- WINDTREE THERAPEUTICS INC /DE/ fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2015 was 159.00%.
| Period end | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2016-12-31 | 0.00% 10-K · filed 2017-03-31 | |||
| 2016-09-30 | 0.00% 10-Q · filed 2016-11-14 | |||
| 2016-06-30 | 0.00% 10-Q · filed 2016-08-10 | |||
| 2015-12-31 | 159.00% 10-K · filed 2017-03-31 | |||
| 2015-09-30 | 99.00% 10-Q · filed 2016-11-14 | |||
| 2015-06-30 | 82.00% 10-Q · filed 2016-08-10 | |||
| 2013-09-30 | 101.00% 10-Q · filed 2013-11-12 | |||
| 2013-06-30 | 101.00% 10-Q · filed 2013-08-08 | |||
| 2013-03-31 | 101.00% 10-Q · filed 2013-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |